SMH
ABBV icon

Sanders Morris Harris’s AbbVie ABBV Stock Holding History

Sanders Morris Harris’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$480K Sell
1,908
-18,921
-91% -$4.07M 0.28% 41
2026
Q1 		$4.53M Buy
+20,829
New +$4.62M 0.72% 28
2025
Q4 		– Sell
-21,512
Closed -$4.98M – 37
2025
Q3 		$4.98M Buy
21,512
+18,639
+649% +$3.8M 0.66% 24
2025
Q2 		$533K Sell
2,873
-19,558
-87% -$3.63M 0.13% 67
2025
Q1 		$4.64M Sell
22,431
-100
-0.4% -$19.4K 0.72% 23
2024
Q4 		$4M Sell
22,531
-300
-1% -$55.2K 0.6% 27
2024
Q3 		$4.51M Sell
22,831
-60
-0.3% -$11.2K 0.75% 20
2024
Q2 		$3.93M Hold
22,891
– – 0.64% 32
2024
Q1 		$4.17M Buy
22,891
+3,393
+17% +$585K 0.77% 22
2023
Q4 		$3.13M Sell
19,498
-3,598
-16% -$525K 1.54% 14
2023
Q3 		$3.41M Hold
23,096
– – 0.7% 22
2023
Q2 		$3.12M Buy
23,096
+19,498
+542% +$2.86M 0.69% 20
2023
Q1 		$573K Sell
3,598
-19,498
-84% -$2.98M 0.2% 46
2022
Q4 		$3.73M Hold
23,096
– – 1.41% 11
2022
Q3 		$3.18M Sell
23,096
-62
-0.3% -$8.9K 0.78% 23
2022
Q2 		$3.56M Hold
23,158
– – 0.78% 26
2022
Q1 		$3.75M Buy
23,158
+62
+0.3% +$9.01K 0.73% 25
2021
Q4 		$3.11M Hold
23,096
– – 0.54% 33
2021
Q3 		$2.55M Sell
23,096
-160
-0.7% -$18.3K 0.46% 41
2021
Q2 		$2.68M Buy
23,256
+160
+0.7% +$18K 0.52% 40
2021
Q1 		$2.44M Buy
23,096
+598
+3% +$64K 0.52% 42
2020
Q4 		$2.51M Hold
22,498
– – 0.57% 42
2020
Q3 		$1.97M Buy
22,498
+9,358
+71% +$881K 0.54% 41
2020
Q2 		$1.3M Buy
13,140
+5,738
+78% +$505K 0.63% 27
2020
Q1 		$328K Sell
7,402
-19,378
-72% -$1.65M 0.32% 75
2019
Q4 		$2.39M Sell
26,780
-1,850
-6% -$154K 0.54% 46
2019
Q3 		$2.07M Buy
28,630
+1,400
+5% +$96K 0.5% 49
2019
Q2 		$1.99M Buy
+27,230
New +$2.14M 0.52% 45
2016
Q2 		– Sell
-17,566
Closed -$1M – 241
2016
Q1 		$1M Buy
+17,566
New +$979K 0.17% 119

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Sanders Morris Harris's ABBV Position: Q2 2026 in Review

Sanders Morris Harris reduced its AbbVie (ABBV) stake by 91% in Q2 2026, selling an estimated $4.07M and leaving 1,908 shares worth $480K. The position accounts for 0.28% of the portfolio, ranked #41.

Sanders Morris Harris first reported a position in ABBV in Q1 2016 and has held it in 29 quarters since. The position peaked at $4.98M in Q3 2025. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Sanders Morris Harris held 1,908 shares of AbbVie worth $480K as of Q2 2026.
  • Sanders Morris Harris sold 18,921 AbbVie shares in Q2 2026, an estimated $4.07M.
  • AbbVie made up 0.28% of Sanders Morris Harris's portfolio in Q2 2026, its #41 holding.
  • Sanders Morris Harris first reported a position in AbbVie in Q1 2016 and has held it in 29 quarters since.
  • Sanders Morris Harris's AbbVie position peaked at $4.98M in Q3 2025.
  • 803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Sanders Morris Harris's 13F filing for Q2 2026, filed 7 Jul 2026.